| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.9M | — |
| Cost of Revenue | $2.2M | +1558.5% |
| Gross Profit | $2.6M | +2889.6% |
| R&D Expense | $3.3M | +119.9% |
| SG&A Expense | $11.5M | +236.9% |
| Operating Income | -$12.2M | -147.1% |
| Pre-tax Income | -$9.0M | -149.6% |
| Income Tax | -$16K | -103.8% |
| Net Income | -$9.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $67K | +5103.0% |
| Inventory | $3.1M | -28.9% |
| Current Assets | $4.9M | +4997.7% |
| Total Assets | $6.1M | -74.0% |
| Current Liabilities | $9.8M | -22.8% |
| Long-term Debt | $9.9M | — |
| Total Liabilities | $15.6M | +23.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.0M | -416.1% |
| Capital Expenditures | $88K | +573.2% |
| Investing Cash Flow | -$88K | -100.4% |
| Financing Cash Flow | $11.1M | +161.7% |
| Free Cash Flow | -$10.1M | -417.1% |
| -123.2% |
| EPS (Basic) | -$0.71 | +9.0% |
| EPS (Diluted) | -$0.71 | +9.0% |
| Stockholders' Equity |
| -$9.5M |
| +23.8% |